Showing results (161-170 of 193) with videos related to
Sort By:
Pageof 20
Journal of the International AIDS Society|July 5, 2023
Combination HIV prevention during pregnancy and the post-partum period in Malawi and Zambia: a mathematical modelling analysisKimberly A Powers, Wilbroad Mutale, Nora E Rosenberg, et al.Gates Open Research|February 2, 2019
The Zambian Preterm Birth Prevention Study (ZAPPS): Cohort characteristics at enrollmentMarcela C Castillo, Nurain M Fuseini, Katelyn Rittenhouse, et al.Plos One|May 27, 2010
Serum phosphate predicts early mortality in adults starting antiretroviral therapy in Lusaka, Zambia: a prospective cohort studyDouglas C Heimburger, John R Koethe, Christopher Nyirenda, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 1, 2014
Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, ZambiaAllen C Bateman, Groesbeck P Parham, Vikrant V Sahasrabuddhe, et al.Journal of Clinical Microbiology|August 30, 2013
Simultaneous detection of major drug resistance mutations in the protease and reverse transcriptase genes for HIV-1 subtype C by use of a multiplex allele-specific assayGuoqing Zhang, Fangping Cai, Zhiyong Zhou, et al.JAMA|October 24, 2007
Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in ZambiaCarolyn Bolton-Moore, Mwangelwa Mubiana-Mbewe, Ronald A Cantrell, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 31, 2021
A Randomized Trial of Point-of-Care Early Infant Human Immunodeficiency Virus (HIV) Diagnosis in ZambiaCarla J Chibwesha, Katie R Mollan, Catherine E Ford, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2019
Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF TrialDorothy Sebikari, Mona Farhad, Terry Fenton, et al.Plos Medicine|February 20, 2010
Effectiveness of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in women previously exposed to a single intrapartum dose of nevirapine: a multi-country, prospective cohort studyJeffrey S A Stringer, Michelle S McConnell, James Kiarie, et al.The Lancet. HIV|September 12, 2021
Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trialJoan T Price, Bellington Vwalika, Bethany L Freeman, et al.Pageof 20